Envista (NYSE:NVST) announced today that the FDA cleared the Nobel Biocare N1 implant system of instruments, prosthetic components and surgical protocols. The N1 system includes an implant designed for immediate placement and predictable insertion torques, providing a trioval conical connection for the abutment to slide into place. Additionally, the system has an emergence profile designed […]
Nobel Biocare Holdings AG
Align Technology announces Nobel Biocare implant software integration
Align Technology (NSDQ:ALGN) said today it expanded workflow options for its iTero intraoral scanner, now expanded to include digital workflow for Nobel Biocare implants. Customers using San Jose, Calif.-based company’s iTero system can now order Nobel Biocare implant cases through detnal labs, which in turn can order NobelProcera single-unit restorations for their doctors. “Integrating the digital workflow […]
Nobel Biocare notches a mixed win in patent war with Straumann’s Neodent
Danaher (NYSE:DHR) subsidiary Nobel Biocare notched a mixed win in the initial determination from the U.S. International Trade Commission in its patent war with a Straumann subsidiary and a Brazilian manufacturer over dental implant technology. Nobel Biocare filed a complaint in October 2014 with the ITC, asking for an investigation of the importation and sale of the Neodent DriveCM dental implant, made […]
Nobel Biocare takes patent war to the border
Danaher becomes dental giant with $2.1B Nobel Biocare buy

Covidien acquires Reverse Medical | Medtech Wall Street news for the week of August 25, 2014
Nobel Biocare sues Brazilian rival Neodent over dental implant
Nobel Biocare’s Q2 profits double as it fields buyout interest
Nobel Biocare settles $450M class action for $1.3M

Nobel Biocare Holding may be able to settle a class action lawsuit involving 1,000s of dentists for $1.3 million after a federal judge tentatively OK’d the deal.
The class action, headed by Dr. Jason Yamada, includes any U.S. dentists who bought Nobel implant products (except the company’s NobelDirect Groovy device) – more than 2,900 dentists.
VCs press Senate on “IPO On Ramp” bill | Wall Street Beat

The National Venture Capital Assn. is spearheading a drive to get a bill through the U.S. Senate that would make it easier for small companies to raise money by going public.
The "IPO On Ramp" measure would ease the regulatory requirements for IPOs and temporarily reduce the reporting burdens imposed by the Sarbanes-Oxley Act.
Sorin’s 2011 profits rise despite flat sales | Earnings Roundup

Sorin Group (BIT:SRN) managed to raise its bottom line despite flat sales for 2011 by raising its gross margin via restructuring, posting a profit increase of 48.3% for the year.
The Milanese cardiovascular device maker reported profits of $75.2 million (~€58.0 million) on sales of $963.4 million (~€743.4 million), compared with profits of $50.7 million (~€39.1 million) on sales of $966.5 million (~€745.8 million) during 2010.